Podcast - The New Rules of Healthcare Fraud Enforcement
Hospice Insights Podcast - Hospice Audit Updates: UPICs May Pick You for a Prepayment Review
Strategic Alignment With Collaboration Is Essential to a Life Sciences M&A Exit — Troutman Pepper Locke Podcast
AI's Hidden Power Grid: Data Centers, Subsea Cables, and the New Infrastructure Arms Race — The Good Bot: Artificial Intelligence, Health Care, and the Law
Charting a Course for Collections: Diagnosing Compliance and Privacy Risks in Medical Debt — The Consumer Finance Podcast
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 275: Strategies for Building the Life Sciences Talent Pipeline with NIIMBL’s John Balchunas
Health+Tech - Healthcare Private Equity Conference Recap
Health+Tech - From Software to Scrutiny: Navigating FDA Inspections Under the New QMSR
Health+Tech - The Perfect Storm: Cyber Threats, Regulation and AI in Healthcare
Podcast - Inside Telehealth's Growth, Regulation and Access
Health-e Law Podcast, Episode 25 | Human-in-the-Loop: Bringing AI to Skilled Nursing Facilities
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 274: Advancing Cancer Immunotherapy with Dr. Besim Ogretmen of Lipo-Immuno Tech & MUSC
False Claims Act Insights - Healthcare Compensation and Referrals: Avoiding Compliance Pitfalls in Physician Deals
DOJ’s Bulk Sensitive Data Transfer Rule: Key Insights for Health Care Compliance Teams – Diagnosing Health Care
Hospice Insights Podcast - High Risk Hospices Are in the Hot Seat Across Six States
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 273: Navigating FDA Regulation for Life Sciences Companies with Christin Carey of Maynard Nexsen
PODCAST – 2026 To Do: HIPAA Compliance
2026 To Do: HIPAA Compliance
Health-E Law Podcast, Episode 24 | ViVE 2026: AI and the Future of Healthcare
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 272: Humanism and Transplant Care with Dr. Joseph Scalea of MUSC
Key Takeaways - The closure of the Strait of Hormuz following the U.S.-Iran conflict is disrupting global health care supply chains and increasing costs for critical medical products....more
Key Takeaways - The Centers for Medicare and Medicaid Services has directed states to expedite Medicaid provider revalidation, requiring two-year revalidation strategies within 30 days and focusing on high-risk providers not...more
Department of Justice (DOJ) announced the Fraud Oversight through Careful Use of Statistics (FOCUS) Initiative on April 30, 2026, a new effort designed to increase False Claims Act (FCA) enforcement through partnerships with...more
Key Takeaways - The Food & Drug Administration issued a Warning Letter citing a drug company for inappropriate use of AI in pharmaceutical manufacturing, marking what appears to be the first time the agency has specifically...more
Fashion, beauty, and wearable technology brands are heading into 2026 with a lot more to think about concerning data privacy. What used to feel like a back-end legal issue is now shaping how companies design products,...more
On April 23, 2026, the Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) jointly announced the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway....more
Pharmacy Benefit Manager (“PBM”) arrangements have long relied on rebates with limited transparency into true drug costs. Recent regulatory and market developments represent a shift toward greater transparency and better net...more
THL Partners will acquire Celerion from H.I.G. Capital for $1.8 billion, according to news releases and industry reports. Celerion, formed in 2010 and based in Lincoln, Nebraska, is a global provider of clinical...more
Significant revisions to the Maine Substance Use Testing Law, 26 Maine Rev. Stat. 681 et seq., will take effect on July 29, 2026. Maine House Bill 1425 (2025-2026). New Types of Tests Permitted- Maine law currently...more
Introduction - The Department of Justice (“DOJ” or the “Department”) has announced the Fraud Oversight through Careful Use of Statistics (“FOCUS”) Initiative to encourage proactive engagement with data miners seeking to...more
Maryland AG Anthony Brown and North Carolina AG Jeff Jackson announced separate settlements with Mylan resolving allegations that the company used anticompetitive tactics to maintain EpiPen’s market dominance and drive up...more
The United States Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) recently issued a press release announcing a final order that significantly impacts the federal treatment of marijuana under the...more
There were massive cheers in the marijuana industry when Acting Attorney General Todd Blanche issued a final order last week that rescheduled FDA-approved marijuana medications and state-licensed medical marijuana. And for...more
The “Make America Healthy Again” (MAHA) movement has rapidly turned food additive regulation from a niche issue into a mainstream political and business priority. Longstanding debates over ingredient safety, chemical...more
The Department of Justice (DOJ) moved certain medical marijuana products to Schedule III, broadening workplace rights and employer responsibilities. Employees using prescribed medical marijuana are now protected from...more
ISSUES AND UPDATES - Trade Secret Litigation Trends in Life Sciences - Trade secret litigation has risen sharply in recent years, driven by increased employee mobility, complex collaboration agreements, and heightened...more
As federal and state governments continue to prioritize drug pricing reform, employers across the nation face a rapidly evolving landscape of legal and regulatory scrutiny regarding the management of their health plans. A...more
I was sitting with a model of care (MOC) recently — not skimming it, actually reading it — and it brought back a conversation I had with a colleague that I have not been able to shake....more
Foley & Lardner LLP (Foley) secured a fully favorable Administrative Law Judge (ALJ) decision overturning $3,261,046.50 in Medicare overpayments assessed by the Centers for Medicare & Medicaid Services (CMS) against a Florida...more
On December 16, 2025, the European Commission (the "Commission") published a proposal for a European Biotech Act (the "Proposed Biotech Act" or "Proposal"). The Proposed Biotech Act is a central pillar of the Commission's...more
Employee privacy continues to be a complex and evolving area. As workplace technology advances and states enact new protections, employers are increasingly called upon to balance business interests with employees’ reasonable...more
On April 30, 2026, the Department of Justice’s (“DOJ”) National Fraud Enforcement Division (“Fraud Division”) announced the formation of the West Coast Health Care Fraud Strike Force, a multi-district enforcement initiative...more
The Commonwealth of Pennsylvania has alleged an AI company’s chatbot engaged in the unauthorized practice of medicine. This lawsuit not only signals how state regulators are potentially evaluating AI-driven health...more
The Iowa legislature adjourned sine die on May 3, 2026, after marathon caucuses and floor debate through the night on Saturday, May 2, and most of the day on Sunday, May 3. Slated for 100 days, the legislature extended 12...more
Peptides have emerged as one of the most rapidly evolving areas in modern medicine. According to those that promote the benefits of peptides, these short chains of amino acids can play critical roles in numerous biological...more